GlassScriptPhysician profile
Ninad C Pendharkar
NPI 1295936458
$1,300.35
in general payments reported to CMS, 2019-2025
17 companies · $401 in 2025
The $401 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $292 · 2020: $91.19 · 2021: $61.94 · 2022: $77.99 · 2023: $140 · 2024: $236 · 2025: $401.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $777.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $777.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $456.08 | 2019-2025 | Tremfya |
| Abbvie INC. | $198.11 | 2019-2024 | |
| Pfizer INC. | $111.92 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $72.13 | 2022-2025 | Sotyktu |
| Leo Pharma INC. | $61.94 | 2020-2022 | |
| Ucb, INC. | $61.70 | 2021-2025 | Bimzelx |
| Amgen INC. | $56.46 | 2020-2025 | Otezla, Otezla |
| Sun Pharmaceutical Industries INC. | $52.08 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $44.05 | 2024-2025 | |
| Janssen Scientific Affairs, LLC | $37.99 | 2022 | |
| Galderma Laboratories, L.P. | $35.46 | 2024-2025 | Nemluvio |
| Organon LLC | $29.54 | 2023 | Hadlima |
| Lilly USA, LLC | $24.92 | 2025 | Ebglyss, Taltz |
| Dermavant Sciences, INC. | $16.81 | 2024 | Vtama |
| Strata Skin Sciences, INC. | $14.43 | 2025 | Xtrac |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $14.09 | 2019 | |
| Celgene Corporation | $12.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ninad Pendharkar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.